25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aurinia Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Aurinia Pharmaceuticals Inc together

I guess you are interested in Aurinia Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aurinia Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aurinia Pharmaceuticals Inc

I send you an email if I find something interesting about Aurinia Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Aurinia Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Aurinia Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.66
Expected worth in 1 year
$2.59
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-0.07
Return On Investment
-0.8%

For what price can you sell your share?

Current Price per Share
$9.37
Expected price per share
$8.5 - $12.43
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aurinia Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$9.37
Intrinsic Value Per Share
$-0.78 - $19.79
Total Value Per Share
$1.88 - $22.45

2.2. Growth of Aurinia Pharmaceuticals Inc (5 min.)




Is Aurinia Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$388m$395m-$22.4m-6.0%

How much money is Aurinia Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.6m-$19.2m$13.6m242.3%
Net Profit Margin-14.6%-55.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Aurinia Pharmaceuticals Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#154 / 944

Most Revenue
#124 / 944

Most Profit
#453 / 944

Most Efficient
#332 / 944
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aurinia Pharmaceuticals Inc?

Welcome investor! Aurinia Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Aurinia Pharmaceuticals Inc.

First you should know what it really means to hold a share of Aurinia Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Aurinia Pharmaceuticals Inc is $9.37. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aurinia Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aurinia Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.66. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aurinia Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.101.1%-0.04-0.4%-0.13-1.4%-0.19-2.0%-0.14-1.5%
Usd Book Value Change Per Share0.131.4%-0.02-0.2%-0.06-0.6%0.091.0%0.060.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.131.4%-0.02-0.2%-0.06-0.6%0.091.0%0.060.6%
Usd Price Per Share7.33-6.76-8.18-12.01-8.36-
Price to Earnings Ratio18.60-68.68--17.94--1.96--10.65-
Price-to-Total Gains Ratio54.79-25.61--520.97--272.81--124.75-
Price to Book Ratio2.75-2.61-2.98-4.93-8.17-
Price-to-Total Gains Ratio54.79-25.61--520.97--272.81--124.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.37
Number of shares106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.09
Usd Total Gains Per Share-0.020.09
Gains per Quarter (106 shares)-1.949.54
Gains per Year (106 shares)-7.7438.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-8-1803828
20-15-2607666
30-23-340114104
40-31-420153142
50-39-500191180
60-46-580229218
70-54-660267256
80-62-740305294
90-70-820343332
100-77-900382370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%3.037.00.07.5%13.089.02.012.5%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%14.026.00.035.0%38.066.00.036.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0104.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%14.026.00.035.0%38.066.00.036.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aurinia Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.134-0.018+114%-0.055+141%0.090+49%0.058+131%
Book Value Per Share--2.6642.579+3%2.759-3%2.589+3%1.616+65%
Current Ratio--5.6035.510+2%8.048-30%11.942-53%14.355-61%
Debt To Asset Ratio--0.2940.303-3%0.214+38%0.188+57%0.222+32%
Debt To Equity Ratio--0.4160.435-4%0.284+47%0.242+72%0.311+34%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--1255009830.0001151784682.500+9%1419815982.960-12%1984562706.532-37%1366036149.834-8%
Eps--0.099-0.039+140%-0.135+237%-0.189+292%-0.143+245%
Ev To Ebitda Ratio--15.006-2.257+115%-27.149+281%-32.399+316%-25.287+269%
Ev To Sales Ratio--4.6305.385-14%9.323-50%4510.468-100%4494.365-100%
Free Cash Flow Per Share--0.1160.050+133%-0.066+157%-0.126+209%-0.093+180%
Free Cash Flow To Equity Per Share--0.097-0.005+105%-0.064+166%0.078+25%0.057+71%
Gross Profit Margin--0.8100.099+716%1.000-19%0.820-1%0.910-11%
Intrinsic Value_10Y_max--19.791--------
Intrinsic Value_10Y_min---0.781--------
Intrinsic Value_1Y_max--0.037--------
Intrinsic Value_1Y_min---0.324--------
Intrinsic Value_3Y_max--1.595--------
Intrinsic Value_3Y_min---0.766--------
Intrinsic Value_5Y_max--4.941--------
Intrinsic Value_5Y_min---0.978--------
Market Cap1341587304.960+20%1067621830.000976263432.500+9%1171562232.960-9%1721576706.532-38%1197581174.834-11%
Net Profit Margin--0.212-0.146+169%-0.550+360%-272.697+128887%-284.654+134534%
Operating Margin--0.236-0.100+142%-0.597+352%-202.661+85860%-196.231+83139%
Operating Ratio--0.8271.127-27%1.634-49%265.439-100%321.499-100%
Pb Ratio3.517+22%2.7522.609+5%2.979-8%4.934-44%8.171-66%
Pe Ratio23.776+22%18.60068.679-73%-17.935+196%-1.960+111%-10.653+157%
Price Per Share9.370+22%7.3306.760+8%8.183-10%12.012-39%8.358-12%
Price To Free Cash Flow Ratio20.189+22%15.79310.258+54%-33.028+309%9.448+67%-6.110+139%
Price To Total Gains Ratio70.034+22%54.78625.607+114%-520.970+1051%-272.813+598%-124.748+328%
Quick Ratio--8.8658.655+2%12.518-29%16.069-45%17.478-49%
Return On Assets--0.026-0.011+141%-0.040+252%-0.064+347%-0.087+434%
Return On Equity--0.037-0.016+142%-0.049+232%-0.077+307%-0.118+418%
Total Gains Per Share--0.134-0.018+114%-0.055+141%0.090+49%0.058+131%
Usd Book Value--388002000.000372512000.000+4%395003000.000-2%371384000.000+4%231737150.000+67%
Usd Book Value Change Per Share--0.134-0.018+114%-0.055+141%0.090+49%0.058+131%
Usd Book Value Per Share--2.6642.579+3%2.759-3%2.589+3%1.616+65%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--1255009830.0001151784682.500+9%1419815982.960-12%1984562706.532-37%1366036149.834-8%
Usd Eps--0.099-0.039+140%-0.135+237%-0.189+292%-0.143+245%
Usd Free Cash Flow--16900000.0007208788.250+134%-9468750.000+156%-18042302.400+207%-13297051.200+179%
Usd Free Cash Flow Per Share--0.1160.050+133%-0.066+157%-0.126+209%-0.093+180%
Usd Free Cash Flow To Equity Per Share--0.097-0.005+105%-0.064+166%0.078+25%0.057+71%
Usd Market Cap1341587304.960+20%1067621830.000976263432.500+9%1171562232.960-9%1721576706.532-38%1197581174.834-11%
Usd Price Per Share9.370+22%7.3306.760+8%8.183-10%12.012-39%8.358-12%
Usd Profit--14350000.000-5638000.000+139%-19297750.000+234%-26375500.000+284%-18910700.000+232%
Usd Revenue--67771000.00055090250.000+23%39713250.000+71%29028050.000+133%14555225.000+366%
Usd Total Gains Per Share--0.134-0.018+114%-0.055+141%0.090+49%0.058+131%
 EOD+4 -4MRQTTM+34 -4YOY+22 -165Y+25 -1310Y+25 -13

3.3 Fundamental Score

Let's check the fundamental score of Aurinia Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1523.776
Price to Book Ratio (EOD)Between0-13.517
Net Profit Margin (MRQ)Greater than00.212
Operating Margin (MRQ)Greater than00.236
Quick Ratio (MRQ)Greater than18.865
Current Ratio (MRQ)Greater than15.603
Debt to Asset Ratio (MRQ)Less than10.294
Debt to Equity Ratio (MRQ)Less than10.416
Return on Equity (MRQ)Greater than0.150.037
Return on Assets (MRQ)Greater than0.050.026
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Aurinia Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.759
Ma 20Greater thanMa 508.924
Ma 50Greater thanMa 1007.998
Ma 100Greater thanMa 2007.232
OpenGreater thanClose9.650
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Fundamental data was last updated by Penke on 2024-12-05 13:12:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aurinia Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 21.2% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 21.2%. The company is making a huge profit. +2
  • The TTM is -14.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ21.2%TTM-14.6%+35.8%
TTM-14.6%YOY-55.0%+40.4%
TTM-14.6%5Y-27,269.7%+27,255.0%
5Y-27,269.7%10Y-28,465.4%+1,195.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.2%-108.6%+129.8%
TTM-14.6%-221.4%+206.8%
YOY-55.0%-207.4%+152.4%
5Y-27,269.7%-346.2%-26,923.5%
10Y-28,465.4%-470.4%-27,995.0%
4.3.1.2. Return on Assets

Shows how efficient Aurinia Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • 2.6% Return on Assets means that Aurinia Pharmaceuticals Inc generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.6%TTM-1.1%+3.7%
TTM-1.1%YOY-4.0%+2.9%
TTM-1.1%5Y-6.4%+5.4%
5Y-6.4%10Y-8.7%+2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-11.6%+14.2%
TTM-1.1%-12.0%+10.9%
YOY-4.0%-11.2%+7.2%
5Y-6.4%-12.6%+6.2%
10Y-8.7%-14.1%+5.4%
4.3.1.3. Return on Equity

Shows how efficient Aurinia Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • 3.7% Return on Equity means Aurinia Pharmaceuticals Inc generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 3.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.7%TTM-1.6%+5.2%
TTM-1.6%YOY-4.9%+3.3%
TTM-1.6%5Y-7.7%+6.1%
5Y-7.7%10Y-11.8%+4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%-14.5%+18.2%
TTM-1.6%-16.0%+14.4%
YOY-4.9%-14.6%+9.7%
5Y-7.7%-18.5%+10.8%
10Y-11.8%-19.2%+7.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aurinia Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aurinia Pharmaceuticals Inc is operating .

  • Measures how much profit Aurinia Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 23.6% means the company generated $0.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 23.6%. The company is operating efficient. +1
  • The TTM is -10.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ23.6%TTM-10.0%+33.7%
TTM-10.0%YOY-59.7%+49.6%
TTM-10.0%5Y-20,266.1%+20,256.1%
5Y-20,266.1%10Y-19,623.1%-643.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.6%-204.0%+227.6%
TTM-10.0%-316.8%+306.8%
YOY-59.7%-215.6%+155.9%
5Y-20,266.1%-376.1%-19,890.0%
10Y-19,623.1%-480.3%-19,142.8%
4.3.2.2. Operating Ratio

Measures how efficient Aurinia Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.83 means that the operating costs are $0.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 0.827. The company is less efficient in keeping operating costs low.
  • The TTM is 1.127. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.827TTM1.127-0.301
TTM1.127YOY1.634-0.507
TTM1.1275Y265.439-264.312
5Y265.43910Y321.499-56.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8272.284-1.457
TTM1.1273.198-2.071
YOY1.6343.247-1.613
5Y265.4394.651+260.788
10Y321.4996.419+315.080
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aurinia Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aurinia Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.60 means the company has $5.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 5.603. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.510. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.603TTM5.510+0.094
TTM5.510YOY8.048-2.538
TTM5.5105Y11.942-6.432
5Y11.94210Y14.355-2.413
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6033.586+2.017
TTM5.5103.869+1.641
YOY8.0484.644+3.404
5Y11.9425.971+5.971
10Y14.3556.240+8.115
4.4.3.2. Quick Ratio

Measures if Aurinia Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.86 means the company can pay off $8.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 8.865. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.655. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.865TTM8.655+0.209
TTM8.655YOY12.518-3.863
TTM8.6555Y16.069-7.414
5Y16.06910Y17.478-1.408
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8653.093+5.772
TTM8.6553.392+5.263
YOY12.5184.304+8.214
5Y16.0695.953+10.116
10Y17.4786.435+11.043
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aurinia Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aurinia Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aurinia Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that Aurinia Pharmaceuticals Inc assets are financed with 29.4% credit (debt) and the remaining percentage (100% - 29.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 0.294. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.303. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.303-0.009
TTM0.303YOY0.214+0.089
TTM0.3035Y0.188+0.115
5Y0.18810Y0.222-0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2940.346-0.052
TTM0.3030.347-0.044
YOY0.2140.313-0.099
5Y0.1880.365-0.177
10Y0.2220.383-0.161
4.5.4.2. Debt to Equity Ratio

Measures if Aurinia Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 41.6% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aurinia Pharmaceuticals Inc:

  • The MRQ is 0.416. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.435. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.416TTM0.435-0.019
TTM0.435YOY0.284+0.151
TTM0.4355Y0.242+0.192
5Y0.24210Y0.311-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4160.393+0.023
TTM0.4350.432+0.003
YOY0.2840.388-0.104
5Y0.2420.455-0.213
10Y0.3110.498-0.187
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aurinia Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Aurinia Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of 18.60 means the investor is paying $18.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aurinia Pharmaceuticals Inc:

  • The EOD is 23.776. Based on the earnings, the company is fair priced.
  • The MRQ is 18.600. Based on the earnings, the company is fair priced.
  • The TTM is 68.679. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD23.776MRQ18.600+5.176
MRQ18.600TTM68.679-50.080
TTM68.679YOY-17.935+86.615
TTM68.6795Y-1.960+70.640
5Y-1.96010Y-10.653+8.693
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD23.776-2.180+25.956
MRQ18.600-2.507+21.107
TTM68.679-3.153+71.832
YOY-17.935-3.242-14.693
5Y-1.960-5.992+4.032
10Y-10.653-6.690-3.963
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aurinia Pharmaceuticals Inc:

  • The EOD is 20.189. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.793. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 10.258. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD20.189MRQ15.793+4.395
MRQ15.793TTM10.258+5.536
TTM10.258YOY-33.028+43.286
TTM10.2585Y9.448+0.810
5Y9.44810Y-6.110+15.558
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD20.189-2.879+23.068
MRQ15.793-3.276+19.069
TTM10.258-3.669+13.927
YOY-33.028-4.485-28.543
5Y9.448-8.015+17.463
10Y-6.110-9.197+3.087
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aurinia Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.75 means the investor is paying $2.75 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aurinia Pharmaceuticals Inc:

  • The EOD is 3.517. Based on the equity, the company is fair priced.
  • The MRQ is 2.752. Based on the equity, the company is underpriced. +1
  • The TTM is 2.609. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.517MRQ2.752+0.766
MRQ2.752TTM2.609+0.142
TTM2.609YOY2.979-0.370
TTM2.6095Y4.934-2.325
5Y4.93410Y8.171-3.237
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5171.964+1.553
MRQ2.7522.056+0.696
TTM2.6092.388+0.221
YOY2.9792.460+0.519
5Y4.9343.697+1.237
10Y8.1714.324+3.847
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aurinia Pharmaceuticals Inc.

4.8.1. Institutions holding Aurinia Pharmaceuticals Inc

Institutions are holding 42.727% of the shares of Aurinia Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc6.47590.001292721626091847.032
2024-09-30Armistice Capital, LLC5.72710.96138200000-2936000-26.3649
2024-09-30TANG CAPITAL MANAGEMENT LLC5.04933.785572295004450000160.1007
2024-09-30NEA Management Company, LLC2.77261.5853396983400
2024-09-30State Street Corp2.05690.00092945060649492.2551
2024-09-30Goldman Sachs Group Inc1.68180.002824080211533646.8021
2024-09-30Geode Capital Management, LLC1.23370.0011176637027680.157
2024-09-30Vanguard Group Inc1.12990.00021617835787235.1148
2024-09-30Morgan Stanley - Brokerage Accounts1.0270.00081470497-505255-25.5728
2024-09-30Nuveen Asset Management, LLC0.94580.00281354247-449183-24.9071
2024-09-30Rock Springs Capital Management LP0.8240.2813117974000
2024-09-30Northern Trust Corp0.69540.0012995689157051.6026
2024-09-30Charles Schwab Investment Management Inc0.51970.0017440508994013.75
2024-09-30Citigroup Inc0.45690.0028654186-51909-7.3516
2024-09-30Trexquant Investment LP0.40720.0541583022339520139.4321
2024-09-30AQR Capital Management LLC0.39690.0058568318366077181.0103
2024-09-30Segall Bryant & Hamill0.39310.056356277590311.6309
2024-09-30SG Americas Securities, LLC0.38250.01465477275353014307.9108
2024-09-30Citadel Advisors Llc0.38190.0008546872-390920-41.6851
2024-09-30JPMorgan Chase & Co0.35120.0003502816-4218-0.8319
Total 32.90886.760147118721+2377077+5.0%

4.9.2. Funds holding Aurinia Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-27iShares Russell 2000 ETF2.58310.04063698458-7728-0.2085
2024-09-30Fidelity Small Cap Index0.95470.03651366974-105179-7.1446
2024-10-31State St Russell Sm/Mid Cp® Indx NL Cl C0.62870.014490020000
2024-11-27iShares Biotechnology ETF0.62180.11318903099050.1018
2024-11-27iShares Russell 2000 Growth ETF0.61680.058588314200
2024-09-30Nuveen Quant Small Cap Equity R60.59190.176884745000
2024-10-31Vanguard Russell 2000 ETF0.42840.0361613394-3808-0.617
2024-10-31GS Glb Sm Cp CORE Eq Base Inc USD Close0.3950.2958565591-54555-8.7971
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.34450.036849325200
2024-10-31Vanguard Health Care ETF0.31310.0157448279-1184-0.2634
2024-09-30Schwab Small-Cap Equity0.29510.472342256510806034.3588
2024-08-31CREF Stock R10.25570.001936604100
2024-11-27iShares Russell 2000 Value ETF0.24540.02233513304540.1294
2024-09-30NT R2000 Index Fund - NL0.22780.036332615180172.52
2024-10-31Schwab Small Cap Index0.22450.036532148500
2024-10-31Goldman Sachs Small Cp Val Insghts Instl0.19590.164728053600
2024-06-30US Equity Small Cap Corporate Cl OF0.19270.651927584900
2024-09-30NT R2000 Index Fund - DC - NL - 20.18240.036326116294173.7407
2024-06-30US Equity Small Cap Pool A0.17880.660425604700
2024-10-31iShares Russell 2000 Small-Cap Idx Instl0.17290.0365247591-15877-6.0262
Total 9.64922.943413815806-61478-0.4%

5.3. Insider Transactions

Insiders are holding 7.207% of the shares of Aurinia Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-11Jeffrey Allen BaileySELL45578.43
2024-08-06Scott Michael HabigSELL182495.31
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
EBIT  -11,942-8,658-20,60011,873-8,7278,286-44116,45616,015
Operating Income  -16,263-4,337-20,6009,905-10,6959,964-73112,47911,748



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets549,361
Total Liabilities161,359
Total Stockholder Equity388,002
 As reported
Total Liabilities 161,359
Total Stockholder Equity+ 388,002
Total Assets = 549,361

Assets

Total Assets549,361
Total Current Assets440,459
Long-term Assets108,902
Total Current Assets
Cash And Cash Equivalents 37,142
Short-term Investments 311,605
Net Receivables 36,483
Inventory 38,714
Other Current Assets 16,515
Total Current Assets  (as reported)440,459
Total Current Assets  (calculated)440,459
+/-0
Long-term Assets
Property Plant Equipment 103,525
Intangible Assets 4,509
Long-term Assets Other 868
Long-term Assets  (as reported)108,902
Long-term Assets  (calculated)108,902
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities78,609
Long-term Liabilities82,750
Total Stockholder Equity388,002
Total Current Liabilities
Short-term Debt 15,945
Accounts payable 8,878
Other Current Liabilities 48,475
Total Current Liabilities  (as reported)78,609
Total Current Liabilities  (calculated)73,298
+/- 5,311
Long-term Liabilities
Capital Lease Obligations 87,851
Long-term Liabilities  (as reported)82,750
Long-term Liabilities  (calculated)87,851
+/- 5,101
Total Stockholder Equity
Common Stock1,206,613
Retained Earnings -937,999
Accumulated Other Comprehensive Income -385
Other Stockholders Equity 119,773
Total Stockholder Equity (as reported)388,002
Total Stockholder Equity (calculated)388,002
+/-0
Other
Capital Stock1,206,613
Cash and Short Term Investments 348,747
Common Stock Shares Outstanding 145,651
Current Deferred Revenue4,304
Liabilities and Stockholders Equity 549,361
Net Debt 50,709
Net Invested Capital 388,002
Net Working Capital 361,850
Property Plant and Equipment Gross 105,902
Short Long Term Debt Total 87,851



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
2,585
2,645
1,873
4,143
4,824
12,547
12,164
13,968
12,217
11,132
30,596
30,155
37,062
38,123
53,859
53,050
50,679
49,709
66,565
75,992
74,434
70,545
64,237
65,205
61,173
53,163
46,236
60,546
54,350
47,806
44,800
38,925
30,637
56,637
53,822
47,975
42,667
30,523
39,117
33,342
26,658
13,313
10,638
10,810
9,547
9,621
8,054
12,535
10,282
15,136
19,336
20,124
14,321
9,739
9,004
7,740
4,160
3,644
3,874
23,328
23,142
63,276
60,179
56,395
52,378
48,008
44,383
38,943
33,567
27,749
30,186
33,250
56,997
219,694
207,800
199,832
189,847
176,410
167,855
157,695
145,863
164,501
151,237
150,844
326,683
314,972
295,278
461,750
463,661
417,078
386,268
360,066
543,367
506,902
482,148
488,293
470,860
451,761
548,900
555,013
548,062
516,634
523,529
549,361
549,361523,529516,634548,062555,013548,900451,761470,860488,293482,148506,902543,367360,066386,268417,078463,661461,750295,278314,972326,683150,844151,237164,501145,863157,695167,855176,410189,847199,832207,800219,69456,99733,25030,18627,74933,56738,94344,38348,00852,37856,39560,17963,27623,14223,3283,8743,6444,1607,7409,0049,73914,32120,12419,33615,13610,28212,5358,0549,6219,54710,81010,63813,31326,65833,34239,11730,52342,66747,97553,82256,63730,63738,92544,80047,80654,35060,54646,23653,16361,17365,20564,23770,54574,43475,99266,56549,70950,67953,05053,85938,12337,06230,15530,59611,13212,21713,96812,16412,5474,8244,1431,8732,6452,585
   > Total Current Assets 
1,657
1,696
803
3,056
3,653
11,212
10,987
12,593
10,758
9,485
28,526
0
0
34,467
49,796
47,659
43,829
41,784
57,435
66,566
64,112
60,596
55,467
55,682
52,286
44,628
38,100
52,846
46,854
40,481
37,272
31,600
23,632
49,740
46,613
40,383
35,323
23,723
32,482
27,206
21,747
8,885
6,506
6,536
5,404
5,597
4,546
9,153
6,579
10,559
11,737
11,755
8,317
5,371
4,910
3,537
444
261
680
4,756
2,094
43,527
40,613
37,181
33,551
29,569
26,285
21,406
16,534
11,102
13,901
17,323
41,418
204,475
192,491
184,885
175,252
161,982
153,799
144,047
132,848
151,424
138,523
138,638
315,137
297,897
278,019
411,640
419,427
372,246
349,689
329,219
513,324
477,618
453,193
459,702
442,539
423,648
415,907
426,469
424,800
398,223
409,666
440,459
440,459409,666398,223424,800426,469415,907423,648442,539459,702453,193477,618513,324329,219349,689372,246419,427411,640278,019297,897315,137138,638138,523151,424132,848144,047153,799161,982175,252184,885192,491204,47541,41817,32313,90111,10216,53421,40626,28529,56933,55137,18140,61343,5272,0944,7566802614443,5374,9105,3718,31711,75511,73710,5596,5799,1534,5465,5975,4046,5366,5068,88521,74727,20632,48223,72335,32340,38346,61349,74023,63231,60037,27240,48146,85452,84638,10044,62852,28655,68255,46760,59664,11266,56657,43541,78443,82947,65949,79634,4670028,5269,48510,75812,59310,98711,2123,6533,0568031,6961,657
       Cash And Cash Equivalents 
1,193
0
134
2,581
2,894
10,545
10,336
5,321
9,511
1,912
16,789
0
30,802
30,379
41,565
39,452
19,851
17,340
33,210
42,291
27,624
21,251
25,107
21,453
14,881
12,277
9,229
19,332
16,706
14,685
15,074
15,673
13,361
41,518
40,374
35,849
32,339
20,808
29,787
26,491
21,118
4,619
6,314
5,848
4,583
5,069
3,981
7,002
6,348
10,173
8,643
7,333
5,924
3,346
1,350
289
185
33
454
4,502
1,819
43,289
39,093
25,533
22,706
19,042
15,728
10,594
5,756
3,492
9,125
12,333
39,649
199,066
179,717
87,546
165,629
131,227
132,302
114,898
117,967
140,359
131,493
134,539
306,019
274,207
264,350
248,758
272,350
156,591
121,561
57,587
231,900
132,542
151,632
86,052
94,172
89,001
81,707
46,397
48,875
64,459
33,407
37,142
37,14233,40764,45948,87546,39781,70789,00194,17286,052151,632132,542231,90057,587121,561156,591272,350248,758264,350274,207306,019134,539131,493140,359117,967114,898132,302131,227165,62987,546179,717199,06639,64912,3339,1253,4925,75610,59415,72819,04222,70625,53339,09343,2891,8194,502454331852891,3503,3465,9247,3338,64310,1736,3487,0023,9815,0694,5835,8486,3144,61921,11826,49129,78720,80832,33935,84940,37441,51813,36115,67315,07414,68516,70619,3329,22912,27714,88121,45325,10721,25127,62442,29133,21017,34019,85139,45241,56530,37930,802016,7891,9129,5115,32110,33610,5452,8942,58113401,193
       Short-term Investments 
0
1,085
0
0
0
0
0
6,471
6,659
6,461
10,223
0
2,663
2,658
2,795
5,396
20,931
21,971
22,595
22,931
35,226
37,923
28,588
32,764
35,206
30,726
27,334
31,881
28,780
23,839
19,908
13,898
8,729
6,614
4,786
3,338
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
857
0
0
0
0
0
0
0
0
0
9,994
9,998
9,999
10,008
9,989
9,997
7,040
2,999
3,047
0
3,050
10,071
94,860
7,833
27,905
17,899
23,985
7,889
3,975
0
0
0
11,913
31,936
143,284
125,979
191,668
197,176
228,813
234,178
286,210
240,104
290,592
295,218
272,533
269,006
291,503
301,614
255,453
297,068
311,605
311,605297,068255,453301,614291,503269,006272,533295,218290,592240,104286,210234,178228,813197,176191,668125,979143,28431,93611,9130003,9757,88923,98517,89927,9057,83394,86010,0713,05003,0472,9997,0409,9979,98910,0089,9999,9989,994000000000857000000000000000003,3384,7866,6148,72913,89819,90823,83928,78031,88127,33430,72635,20632,76428,58837,92335,22622,93122,59521,97120,9315,3962,7952,6582,663010,2236,4616,6596,471000001,0850
       Net Receivables 
265
203
335
136
276
200
141
154
492
363
278
0
0
401
4,434
1,881
2,231
1,438
370
237
288
275
211
384
347
339
302
394
385
362
342
331
397
492
357
297
489
467
398
272
407
250
104
511
735
264
449
1,935
114
228
223
220
279
973
564
212
184
184
179
79
106
100
114
50
92
114
85
55
47
47
49
98
86
123
285
415
109
225
307
759
217
376
248
470
368
3,511
508
1,127
1,018
1,187
4,418
9,814
15,414
20,401
18,173
41,771
13,483
19,046
19,499
37,946
24,089
28,909
25,522
36,483
36,48325,52228,90924,08937,94619,49919,04613,48341,77118,17320,40115,4149,8144,4181,1871,0181,1275083,511368470248376217759307225109415285123869849474755851149250114100106791791841842125649732792202232281141,9354492647355111042504072723984674892973574923973313423623853943023393473842112752882373701,4382,2311,8814,43440100278363492154141200276136335203265
       Inventory 
199
339
335
340
413
467
479
559
581
557
721
710
546
509
568
522
516
590
605
561
561
530
590
613
603
614
643
554
269
277
297
326
257
179
304
442
2,007
1,897
1,906
210
120
181
0
0
0
97
0
0
0
0
133
196
195
0
2,672
2,785
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-109
0
0
0
0
0
0
0
0
0
0
6,757
13,927
15,936
17,376
19,293
19,326
26,266
25,863
25,320
24,752
31,745
33,155
32,820
39,705
39,761
38,853
38,714
38,71438,85339,76139,70532,82033,15531,74524,75225,32025,86326,26619,32619,29317,37615,93613,9276,7570000000000-109000000000000000000002,7852,67201951961330000970001811202101,9061,8972,007442304179257326297277269554643614603613590530561561605590516522568509546710721557581559479467413340335339199
   > Long-term Assets 
928
949
1,071
1,087
1,172
1,335
1,177
1,375
1,460
1,646
2,069
0
0
3,655
4,063
5,391
6,850
7,925
9,130
9,426
10,322
9,949
8,769
9,524
8,887
8,535
8,136
7,701
7,496
7,325
7,528
7,325
7,005
6,897
7,209
7,593
7,344
6,800
6,635
6,136
4,911
4,428
4,132
4,274
4,143
4,024
3,508
3,382
3,703
4,578
7,598
8,369
6,004
4,368
4,094
4,203
3,715
3,383
3,194
18,572
21,048
19,749
19,566
19,214
18,827
18,439
18,098
17,537
17,033
16,647
16,285
15,927
15,579
15,219
15,309
14,947
14,595
14,428
14,056
13,648
13,015
13,077
12,714
12,206
11,546
17,075
17,259
50,110
44,234
44,832
36,579
30,847
30,043
29,284
28,955
28,591
28,321
28,113
132,993
128,544
123,262
118,411
113,863
108,902
108,902113,863118,411123,262128,544132,99328,11328,32128,59128,95529,28430,04330,84736,57944,83244,23450,11017,25917,07511,54612,20612,71413,07713,01513,64814,05614,42814,59514,94715,30915,21915,57915,92716,28516,64717,03317,53718,09818,43918,82719,21419,56619,74921,04818,5723,1943,3833,7154,2034,0944,3686,0048,3697,5984,5783,7033,3823,5084,0244,1434,2744,1324,4284,9116,1366,6356,8007,3447,5937,2096,8977,0057,3257,5287,3257,4967,7018,1368,5358,8879,5248,7699,94910,3229,4269,1307,9256,8505,3914,0633,655002,0691,6461,4601,3751,1771,3351,1721,0871,071949928
       Property Plant Equipment 
530
475
535
475
482
667
616
827
858
928
1,247
1,229
1,215
2,779
2,974
4,127
5,712
6,594
7,627
7,826
8,603
8,197
7,152
7,682
7,099
6,731
6,322
6,000
5,602
5,266
5,312
5,091
4,771
4,548
4,602
4,633
4,350
3,890
3,677
3,276
2,634
2,342
2,159
2,146
1,982
1,822
1,580
1,418
1,264
1,116
934
703
649
516
362
227
88
73
58
47
37
25
59
52
52
51
47
42
36
32
27
26
29
26
32
27
31
50
44
39
41
441
425
406
93
5,922
6,423
9,663
10,275
10,519
10,428
10,083
9,801
9,564
9,262
8,703
8,557
8,655
125,792
121,174
116,567
111,950
108,176
103,525
103,525108,176111,950116,567121,174125,7928,6558,5578,7039,2629,5649,80110,08310,42810,51910,2759,6636,4235,92293406425441413944503127322629262732364247515252592537475873882273625166497039341,1161,2641,4181,5801,8221,9822,1462,1592,3422,6343,2763,6773,8904,3504,6334,6024,5484,7715,0915,3125,2665,6026,0006,3226,7317,0997,6827,1528,1978,6037,8267,6276,5945,7124,1272,9742,7791,2151,2291,247928858827616667482475535475530
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,797
24,380
12,603
5,004
0
0
0
0
0
0
0
0
591
201
199
199
0
0199199201591000000005,00412,60324,38028,797000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
398
475
535
543
620
667
561
548
601
0
823
0
859
877
1,089
1,264
1,138
1,331
1,503
1,600
1,719
1,752
1,617
1,842
1,788
1,804
1,814
1,700
1,894
2,059
2,216
2,234
2,234
2,349
2,607
2,959
2,994
2,910
2,958
2,860
2,277
2,086
1,973
2,128
2,161
2,202
1,929
1,965
2,011
3,461
3,433
3,164
3,182
3,200
3,083
3,133
3,032
2,902
2,787
18,525
20,859
19,579
19,223
18,878
18,489
18,102
17,765
17,354
16,997
16,615
16,258
15,901
15,550
15,193
14,829
14,472
14,116
13,720
13,354
12,951
12,616
12,278
11,931
11,591
11,244
10,944
10,627
11,441
9,332
9,854
9,291
8,926
8,404
7,882
7,338
6,839
6,425
6,101
5,683
5,261
4,977
4,760
4,621
4,509
4,5094,6214,7604,9775,2615,6836,1016,4256,8397,3387,8828,4048,9269,2919,8549,33211,44110,62710,94411,24411,59111,93112,27812,61612,95113,35413,72014,11614,47214,82915,19315,55015,90116,25816,61516,99717,35417,76518,10218,48918,87819,22319,57920,85918,5252,7872,9023,0323,1333,0833,2003,1823,1643,4333,4612,0111,9651,9292,2022,1612,1281,9732,0862,2772,8602,9582,9102,9942,9592,6072,3492,2342,2342,2162,0591,8941,7001,8141,8041,7881,8421,6171,7521,7191,6001,5031,3311,1381,2641,08987785908230601548561667620543535475398
       Other Assets 
0
0
0
0
644
662
0
0
0
584
729
811
859
875
0
1,264
1,139
1,331
1,503
1,599
1,719
1,754
1,617
0
1,786
0
1,813
1,699
1,887
0
2,210
2,235
2,233
2,343
2,627
0
2,975
2,919
2,949
0
2,277
2,089
1,970
2,128
2,151
2,211
1,910
0
2,447
0
6,699
0
0
3,879
3,733
3,985
0
0
3,144
0
0
19,724
19,507
19,162
18,775
18,388
18,051
17,495
16,997
16,615
16,258
15,901
15,550
15,193
15,277
14,920
14,564
658
658
658
358
358
358
209
209
209
209
209
5,736
11,856
386,268
11,838
11,838
11,838
12,355
13,049
13,339
0
1,518
0
0
0
0
0
000001,518013,33913,04912,35511,83811,83811,838386,26811,8565,73620920920920920935835835865865865814,56414,92015,27715,19315,55015,90116,25816,61516,99717,49518,05118,38818,77519,16219,50719,724003,144003,9853,7333,879006,69902,44701,9102,2112,1512,1281,9702,0892,27702,9492,9192,97502,6272,3432,2332,2352,21001,8871,6991,81301,78601,6171,7541,7191,5991,5031,3311,1391,26408758598117295840006626440000
> Total Liabilities 
1,724
1,831
1,004
951
758
1,001
818
1,210
884
1,124
4,039
3,981
1,780
1,954
4,228
3,135
3,120
3,049
3,804
4,034
5,891
5,583
3,203
7,877
8,973
7,234
7,045
8,882
11,992
9,937
10,731
11,132
10,470
10,213
12,674
11,202
14,252
7,936
21,391
19,766
18,788
8,991
3,529
4,734
4,739
3,850
2,824
4,447
3,934
9,228
8,518
7,655
7,910
3,582
5,232
5,532
6,278
6,565
6,768
11,098
9,842
8,655
9,106
7,079
7,272
20,449
16,370
15,405
13,604
11,724
10,647
13,147
21,047
47,031
29,335
32,188
24,104
23,956
25,685
32,353
33,288
25,156
25,369
27,103
53,167
51,564
56,239
62,907
55,911
46,850
54,011
61,894
64,276
58,779
58,380
64,868
65,425
61,353
156,608
163,136
170,108
157,158
158,913
161,359
161,359158,913157,158170,108163,136156,60861,35365,42564,86858,38058,77964,27661,89454,01146,85055,91162,90756,23951,56453,16727,10325,36925,15633,28832,35325,68523,95624,10432,18829,33547,03121,04713,14710,64711,72413,60415,40516,37020,4497,2727,0799,1068,6559,84211,0986,7686,5656,2785,5325,2323,5827,9107,6558,5189,2283,9344,4472,8243,8504,7394,7343,5298,99118,78819,76621,3917,93614,25211,20212,67410,21310,47011,13210,7319,93711,9928,8827,0457,2348,9737,8773,2035,5835,8914,0343,8043,0493,1203,1354,2281,9541,7803,9814,0391,1248841,2108181,0017589511,0041,8311,724
   > Total Current Liabilities 
1,657
1,763
803
883
620
868
744
1,152
834
1,083
4,008
3,950
1,722
1,730
4,027
2,977
2,991
2,936
3,493
3,794
5,361
5,126
2,798
4,403
5,266
3,816
4,115
6,340
9,545
7,934
6,652
7,055
6,930
6,980
9,317
7,655
10,741
4,600
7,570
9,343
9,130
5,455
2,551
3,273
3,245
2,380
1,534
2,960
1,344
2,775
2,136
1,568
2,126
1,224
3,008
3,323
3,672
4,103
4,471
6,948
6,042
4,487
4,734
2,655
2,836
2,397
3,723
3,965
3,617
3,642
3,921
4,766
7,930
8,316
3,627
6,855
8,150
5,311
5,076
6,884
7,261
6,496
7,300
13,515
11,295
14,178
17,143
23,889
31,997
21,151
29,315
37,537
40,646
33,838
34,626
41,765
46,107
42,046
61,661
73,890
77,188
71,052
76,903
78,609
78,60976,90371,05277,18873,89061,66142,04646,10741,76534,62633,83840,64637,53729,31521,15131,99723,88917,14314,17811,29513,5157,3006,4967,2616,8845,0765,3118,1506,8553,6278,3167,9304,7663,9213,6423,6173,9653,7232,3972,8362,6554,7344,4876,0426,9484,4714,1033,6723,3233,0081,2242,1261,5682,1362,7751,3442,9601,5342,3803,2453,2732,5515,4559,1309,3437,5704,60010,7417,6559,3176,9806,9307,0556,6527,9349,5456,3404,1153,8165,2664,4032,7985,1265,3613,7943,4932,9362,9912,9774,0271,7301,7223,9504,0081,0838341,1527448686208838031,7631,657
       Short-term Debt 
464
949
67
68
69
133
105
48
44
40
35
0
0
136
136
132
131
187
245
240
187
188
168
959
1,403
1,326
1,441
1,477
1,625
1,672
1,407
1,715
1,722
1,625
1,313
928
532
237
2,478
3,532
4,750
1,680
14
0
0
0
0
128
0
0
0
0
44
46
46
49
36
28
23
8
1,317
0
0
0
0
0
0
0
0
0
0
0
2,928
0
0
0
4,068
0
0
0
118
106
122
125
6,906
0
0
0
788
1,075
1,112
1,111
1,059
1,009
953
918
936
945
14,970
14,308
15,598
14,723
29,828
15,945
15,94529,82814,72315,59814,30814,9709459369189531,0091,0591,1111,1121,0757880006,9061251221061180004,0680002,928000000000001,31782328364946464400001280000141,6804,7503,5322,4782375329281,3131,6251,7221,7151,4071,6721,6251,4771,4411,3261,4039591681881872402451871311321361360035404448105133696867949464
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000106000000000000000000001,241000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
994
814
736
747
551
734
640
1,103
791
1,043
3,972
3,915
1,651
1,594
3,891
2,845
2,221
2,750
3,248
3,554
4,540
4,869
2,562
3,372
3,787
2,415
2,600
3,285
4,864
4,298
3,063
4,170
3,273
4,932
7,572
6,292
9,798
3,968
4,692
3,586
3,274
3,086
733
1,690
2,034
1,441
950
1,015
856
652
953
479
768
843
978
2,955
1,165
2,070
2,511
1,072
1,104
1,436
2,643
2,283
1,392
2,025
3,351
3,617
2,079
2,149
2,462
2,932
2,863
6,132
3,439
6,665
3,773
5,121
4,886
6,694
7,071
6,200
6,749
13,272
4,153
11,177
13,641
2,212
2,635
2,182
2,535
3,263
3,879
3,267
32,380
40,123
3,087
3,680
4,808
8,854
4,327
5,672
8,415
8,878
8,8788,4155,6724,3278,8544,8083,6803,08740,12332,3803,2673,8793,2632,5352,1822,6352,21213,64111,1774,15313,2726,7496,2007,0716,6944,8865,1213,7736,6653,4396,1322,8632,9322,4622,1492,0793,6173,3512,0251,3922,2832,6431,4361,1041,0722,5112,0701,1652,9559788437684799536528561,0159501,4412,0341,6907333,0863,2743,5864,6923,9689,7986,2927,5724,9323,2734,1703,0634,2984,8643,2852,6002,4153,7873,3722,5624,8694,5403,5543,2482,7502,2212,8453,8911,5941,6513,9153,9721,0437911,103640734551747736814994
       Other Current Liabilities 
199
0
0
68
0
0
0
0
0
0
0
0
0
0
0
0
640
0
0
0
70
69
68
72
76
75
74
78
53
52
55
14
1,292
14
15
16
16
16
16
15
3,287
3,082
734
1,705
2,059
1,459
974
1,028
869
1,564
964
702
94
31
2,663
12
2,131
1,673
1,614
5,574
3,393
4,270
4,516
2,438
1,227
2,180
3,506
3,772
1,370
3,499
3,803
4,648
2,021
8,198
3,509
6,737
191
5,193
4,958
6,766
190
72
311
13,272
118
14,060
17,025
23,771
7,200
2,382
2,372
6,456
4,640
29,562
33,673
40,847
38,936
34,264
38,655
46,066
52,450
44,340
33,589
48,475
48,47533,58944,34052,45046,06638,65534,26438,93640,84733,67329,5624,6406,4562,3722,3827,20023,77117,02514,06011813,272311721906,7664,9585,1931916,7373,5098,1982,0214,6483,8033,4991,3703,7723,5062,1801,2272,4384,5164,2703,3935,5741,6141,6732,131122,66331947029641,5648691,0289741,4592,0591,7057343,0823,287151616161615141,2921455525378747576726869700006400000000000006800199
   > Long-term Liabilities 
66
68
201
68
138
133
74
58
50
41
31
0
0
224
201
159
129
112
311
240
530
458
405
3,474
3,707
3,418
2,930
2,542
2,447
2,002
4,079
4,077
3,540
3,233
3,357
3,547
3,511
3,336
13,821
10,422
9,658
3,536
978
1,461
1,494
1,470
1,290
1,487
2,591
6,453
6,382
6,088
5,784
2,358
2,224
2,209
2,606
2,462
2,297
4,150
3,800
4,168
4,372
4,424
4,436
18,052
12,647
11,440
9,987
8,082
6,726
8,381
13,117
38,715
25,708
25,333
15,954
18,645
20,609
25,469
26,027
18,660
18,069
13,588
41,872
37,386
39,096
39,018
23,914
25,699
24,696
24,357
23,630
24,941
23,754
23,103
19,318
19,307
94,947
89,246
92,920
86,106
82,010
82,750
82,75082,01086,10692,92089,24694,94719,30719,31823,10323,75424,94123,63024,35724,69625,69923,91439,01839,09637,38641,87213,58818,06918,66026,02725,46920,60918,64515,95425,33325,70838,71513,1178,3816,7268,0829,98711,44012,64718,0524,4364,4244,3724,1683,8004,1502,2972,4622,6062,2092,2242,3585,7846,0886,3826,4532,5911,4871,2901,4701,4941,4619783,5369,65810,42213,8213,3363,5113,5473,3573,2333,5404,0774,0792,0022,4472,5422,9303,4183,7073,474405458530240311112129159201224003141505874133138682016866
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315
290
253
0
5,851
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000005,8510253290315000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
291
271
249
246
239
218
197
188
107
93
2,301
3,030
2,926
2,946
3,222
3,429
3,407
3,306
3,318
1,093
1,528
1,690
976
1,461
1,487
1,476
1,277
1,177
2,599
6,465
6,416
6,016
5,756
2,351
2,213
2,213
2,613
2,464
2,303
4,152
3,809
4,168
4,372
4,424
4,436
18,052
12,647
11,440
9,987
8,082
6,726
8,381
13,117
38,715
25,708
25,333
15,954
18,645
20,609
25,469
26,027
18,345
17,779
13,335
41,872
31,535
32,894
11,018
16,295
17,893
16,872
16,562
15,950
17,379
16,323
15,833
12,166
0
8,711
0
0
0
0
0
000008,711012,16615,83316,32317,37915,95016,56216,87217,89316,29511,01832,89431,53541,87213,33517,77918,34526,02725,46920,60918,64515,95425,33325,70838,71513,1178,3816,7268,0829,98711,44012,64718,0524,4364,4244,3724,1683,8094,1522,3032,4642,6132,2132,2132,3515,7566,0166,4166,4652,5991,1771,2771,4761,4871,4619761,6901,5281,0933,3183,3063,4073,4293,2222,9462,9263,0302,3019310718819721823924624927129100000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
847
0
0
0
678
0
0
0
560
0
0
0
442
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000004420005600006780008470000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
862
814
870
3,192
4,066
11,546
11,346
12,759
11,333
10,008
26,557
26,174
35,283
36,168
49,631
49,915
47,559
46,660
62,761
71,958
68,543
64,962
61,034
57,328
52,199
45,929
39,191
51,664
42,357
37,869
34,068
27,793
20,166
46,423
41,148
36,774
28,415
22,586
17,725
13,576
7,870
4,322
7,109
6,076
4,809
5,771
5,230
8,089
6,348
5,908
10,818
12,469
6,411
6,157
3,772
2,208
-2,119
-2,921
-2,894
12,231
13,301
54,621
51,073
49,316
45,106
27,559
28,013
23,538
19,963
16,025
19,539
20,103
35,950
172,663
178,465
167,644
165,743
152,454
142,170
125,342
112,575
139,345
125,868
123,741
273,516
263,408
239,039
398,843
407,750
370,228
332,257
298,172
479,091
448,123
423,768
423,425
405,435
390,408
392,292
391,877
377,954
359,476
364,616
388,002
388,002364,616359,476377,954391,877392,292390,408405,435423,425423,768448,123479,091298,172332,257370,228407,750398,843239,039263,408273,516123,741125,868139,345112,575125,342142,170152,454165,743167,644178,465172,66335,95020,10319,53916,02519,96323,53828,01327,55945,10649,31651,07354,62113,30112,231-2,894-2,921-2,1192,2083,7726,1576,41112,46910,8185,9086,3488,0895,2305,7714,8096,0767,1094,3227,87013,57617,72522,58628,41536,77441,14846,42320,16627,79334,06837,86942,35751,66439,19145,92952,19957,32861,03464,96268,54371,95862,76146,66047,55949,91549,63136,16835,28326,17426,55710,00811,33312,75911,34611,5464,0663,192870814862
   Common Stock
0
0
0
0
11,850
20,727
22,093
0
26,403
25,600
28,552
45,991
55,126
57,933
70,560
67,416
67,181
71,817
89,745
102,609
107,816
105,980
104,133
110,003
115,474
114,872
113,710
135,645
135,345
135,402
141,652
141,843
135,754
166,530
182,418
194,358
193,344
187,804
188,724
181,030
158,371
152,820
168,766
183,317
186,262
192,976
184,084
192,392
201,530
209,370
210,848
193,440
199,207
205,017
199,755
206,791
204,703
200,152
194,392
213,724
207,068
257,084
257,131
257,790
258,494
260,926
261,546
261,645
261,645
261,645
267,516
275,805
299,815
487,965
496,726
498,698
499,200
499,200
503,688
503,699
504,650
543,063
543,824
559,073
790,472
794,932
796,350
986,468
944,328
952,673
954,572
967,159
1,177,051
1,178,807
1,180,884
1,184,020
1,185,309
1,193,019
1,196,480
1,198,560
1,200,218
1,207,982
1,205,554
1,206,613
1,206,6131,205,5541,207,9821,200,2181,198,5601,196,4801,193,0191,185,3091,184,0201,180,8841,178,8071,177,051967,159954,572952,673944,328986,468796,350794,932790,472559,073543,824543,063504,650503,699503,688499,200499,200498,698496,726487,965299,815275,805267,516261,645261,645261,645261,546260,926258,494257,790257,131257,084207,068213,724194,392200,152204,703206,791199,755205,017199,207193,440210,848209,370201,530192,392184,084192,976186,262183,317168,766152,820158,371181,030188,724187,804193,344194,358182,418166,530135,754141,843141,652135,402135,345135,645113,710114,872115,474110,003104,133105,980107,816102,60989,74571,81767,18167,41670,56057,93355,12645,99128,55225,60026,403022,09320,72711,8500000
   Retained Earnings -937,999-952,349-953,071-942,322-915,447-902,000-890,508-864,302-838,256-829,267-793,752-756,122-722,800-672,545-625,535-575,156-619,930-585,866-556,340-539,806-463,326-444,289-428,388-415,960-401,367-383,025-367,318-351,840-348,508-335,388-332,989-281,048-272,715-265,296-262,020-257,753-253,690-248,480-247,747-236,372-231,453-228,933-224,916-205,371-213,451-206,953-213,037-217,084-214,147-205,557-207,203-202,032-192,488-208,552-212,684-203,821-195,009-189,413-195,384-190,975-185,626-169,357-155,336-157,776-176,810-180,246-172,955-174,377-165,421-147,365-127,380-119,417-117,835-111,814-101,147-96,913-87,424-77,714-72,096-65,539-54,816-45,018-42,303-39,843-32,006-27,450-26,214-20,525-17,495-20,915-21,88100-20,106-18,108-15,013-12,899-10,737-9,143-7,718-6,927-5,888-6,036-5,502
   Accumulated Other Comprehensive Income 
-398
-407
-401
-543
-551
-534
-543
-713
0
0
-707
0
0
-941
-990
-946
-1,026
-1,101
472
499
551
574
1,111
1,195
1,272
2,287
2,260
2,426
942
938
982
-5,187
-5,944
2,706
2,933
4,947
3,153
3,033
3,235
5,237
-7,404
0
0
0
-8,713
0
0
0
-9,765
0
0
0
-10,189
0
0
0
-10,869
-174
-213
0
-4,762
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-894
-883
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-805
-799
-792
-794
-852
-1,618
-1,853
-1,527
-1,061
-988
-1,020
-947
-730
-854
-859
-385
-385-859-854-730-947-1,020-988-1,061-1,527-1,853-1,618-852-794-792-799-805-805-805-805-805-805-805-805-805-805-805-805-883-894-805-805-805-805-805-805-805-805-805-805-805-805-805-805-4,7620-213-174-10,869000-10,189000-9,765000-8,713000-7,4045,2373,2353,0333,1534,9472,9332,706-5,944-5,1879829389422,4262,2602,2871,2721,1951,111574551499472-1,101-1,026-946-990-94100-70700-713-543-534-551-543-401-407-398
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,690
25,475
27,138
28,799
23,655
25,621
0
0
39,383
43,889
51,022
54,607
59,014
64,686
74,004
79,188
0
88,885
98,832
0
0
0
0
0
0000098,83288,885079,18874,00464,68659,01454,60751,02243,88939,3830025,62123,65528,79927,13825,47524,69000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
6,762
7,257
7,159
10,662
12,336
21,223
22,626
26,371
26,346
28,115
47,369
0
0
58,991
71,536
68,356
69,110
73,976
89,739
103,466
107,836
106,691
104,941
110,950
116,466
115,739
114,645
136,662
138,329
138,078
144,900
150,816
145,527
171,097
185,580
197,248
199,640
192,509
194,736
185,149
173,051
159,658
7,700
8,385
204,496
201,155
194,643
203,097
219,935
218,592
219,370
204,957
218,633
213,361
209,329
216,355
21,131
10,138
9,881
11,958
16,365
23,258
23,680
23,784
23,789
15,185
15,752
16,388
16,876
17,205
18,124
17,818
17,988
18,492
17,932
18,348
19,266
21,377
22,312
23,815
24,690
25,475
27,138
28,799
23,655
25,621
240,039
33,110
39,383
43,889
51,022
54,607
59,014
64,686
74,004
79,188
85,489
88,885
98,832
109,711
120,788
105,419
112,270
119,773
119,773112,270105,419120,788109,71198,83288,88585,48979,18874,00464,68659,01454,60751,02243,88939,38333,110240,03925,62123,65528,79927,13825,47524,69023,81522,31221,37719,26618,34817,93218,49217,98817,81818,12417,20516,87616,38815,75215,18523,78923,78423,68023,25816,36511,9589,88110,13821,131216,355209,329213,361218,633204,957219,370218,592219,935203,097194,643201,155204,4968,3857,700159,658173,051185,149194,736192,509199,640197,248185,580171,097145,527150,816144,900138,078138,329136,662114,645115,739116,466110,950104,941106,691107,836103,46689,73973,97669,11068,35671,53658,9910047,36928,11526,34626,37122,62621,22312,33610,6627,1597,2576,762



5.4. Balance Sheets

Currency in USD. All numbers in thousands.